September 2023 • PharmaTimes Magazine • 4-5


Contents


Features

Young people choosing to follow their parents into the pharma


Are viruses alive or dead and is it time to find out?


M&As, pharma and the conundrum of people


Global health requires regional solutions for a true access model


Turning the UK into mRNA superpower – getting to the top table?


Analysis

Pharma’s dramatic battle against antimicrobial resistance intensifies


The vital innovation and development of generic pharmaceuticals


Five routes to transforming NHS-industry partnerships


Optimising novel treatments is a defining discussion of our times


The future of manufacturing – beyond supply and demand


SmartPeople

14.
Brave. New. World.
Drilling into demographics to get the edge on equality, diversity and inclusion


29.
Revolution vs renovation
Navigating the trough of disillusionment in digital health


30.
Back to life
Why we should embrace digital health technology in clinical trials


36.
Your moves
Where you're going and why